Rockville , Sept. 12, 2023 (GLOBE NEWSWIRE) -- The global ovulation test market is predicted to expand at 4.1% CAGR through 2033, as per a study published by Fact.MR, a market research and competitive intelligence provider. Worldwide demand for ovulation test kits is anticipated to reach a market valuation of US$ 3.76 billion by the end of 2033. Increasing prevalence of reproductive illnesses, including PCOS (polycystic ovary syndrome), and poor rates of fertility are driving demand for ovulation testing kits.
Get Free Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=8914
Most nations are transitioning towards technological advancements and incorporating digital fertility testing techniques. The growing adoption of ovulation testing, coupled with the availability of various advanced high-precision technologies, fosters market growth. Furthermore, the rising need to prevent unplanned pregnancies creates promising prospects. The increasing female population in reproductive age and the rise in gynecological practices amplify business opportunities.
| Report Attributes | Details |
| Value Projection (2033) | US$ 3.76 Billion |
| Growth Rate (2023-2033) | 4.1% CAGR |
| No. of Pages | 170 pages |
| No. of Tables | 25 Tables |
| No. of Figures | 132 Figures |
Key Takeaways from Market Study
- The global ovulation test market reached US$ 2.41 billion in 2022.
- The United States market was estimated at US$ 648 million in 2022.
- Worldwide sales of ovulation test kits are valued at US$ 2.51 billion in 2023.
- The global market is set to reach US$ 3.76 billion by 2033-end.
- Demand for ovulation tests is projected to rise at a CAGR of 4.1% from 2023 to 2033.
- Based on type, demand for urine-based ovulation test kits is predicted to advance at a CAGR of 4.4% and reach a market value of US$ 2.21 billion by 2033.
- Sales of ovulation test kits in China are forecasted to increase at 6.9% CAGR and reach US$ 677 million by 2033.
- Demand for ovulation test kits in Germany is predicted to increase at a CAGR of 2.8% through 2033.
- The market in Japan is projected to advance at 2.2% CAGR from 2023 to 2033.
“Growing investments in R&D activities by prominent market players to reduce the prices of ovulation test kits is predicted to boost product adoption,” says a Fact.MR analyst.
Home Care Settings Emerging as Prominent End Use of Ovulation Test Kits
Home care settings are anticipated to contribute a notable portion of the global market revenue in the next decade. An evident change in patient attitudes towards self-monitoring specific medical conditions, combined with the wide availability of home test equipment, is creating opportunities for ovulation test kit suppliers in home care settings.
Key Market Players
- Accuquik Test Kits,
- Fairhaven Health LLC,
- Church & Dwight Co., Inc.,
- Fertility Focus Limited,
- HiLin Life Products, Inc.,
- Geratherm Medical AG,
- Nectar Lifesciences Ltd. (NLL),
- SPD Swiss Precision Diagnostics GmbH,
- Prestige Brands Holdings.
Ovulation test kit producers are coming up with a variety of ways to achieve their objectives, including new developments, assuring product quality control, managing supply chain systems, and others. Players in the market are investing in new product launches, which are predicted to help them improve their position.
- bioMérieux, in June 2021, announced its distribution of some particular diagnostics in Europe. The product, REVEAL Rapid AST system, is predicted to strengthen its position in rapid testing kits.
Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=8914
Segmentation of Ovulation Test Industry Research Report
- By Type:
- Urine-based
- Saliva-based
- By End User:
- Hospitals
- Home Care Settings
- Clinics
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the ovulation test market, presenting historical demand data for 2018 to 2022 and forecast statistics for 2023 to 2033.
The study divulges essential insights into the market based on type (urine-based, saliva-based) and end user (hospitals, home care settings, clinics), across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and the MEA).
Explore More Related Studies Published by Fact.MR Research:
Antibiotic Residue Test Kits Market: The antibiotic residue test kit sales are extrapolated to amass a revenue of US$ 333.4 million By 2033-end.
Ready-to-use Laboratory Test Kits Market: North America leads the global market due to the presence of a robust healthcare sector, increasing cases of infectious diseases, and growing awareness among patients.
Nipah Virus Testing Market: The market is further expected to surpass a valuation of USD 3374.95 Million by end of 2032.
About Fact.MR:
Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we delivers deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empowers businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning. With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay ahead in the competitive landscape.
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Sales Team: sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog
